Tony Fong - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Tony Fong's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Tony Fong

Tony Fong

Verified

Managing Editor, GenomeWeb

New York

Biography

Tony Fong is a multiplatform editor at STAT. Previously, he was the senior editor at GenomeWeb and a staff writer at Modern Healthcare and the San Diego Union-Tribune, where he covered the business of healthcare and national healthcare policy. A graduate of the Columbia University Graduate School of Journalism, Tony considers himself a hack, but promising, playwright. He loves the New York Knicks. Wait, no, he hates them. No, no, he loves them...

Final Covers

marketing healthBreaking news fitness various other topics.

Journalist Type

-

Seniority Positions

Industries

Medium Formats

-

Content

Total articles 14

  • PyMouseTracks: Flexible Computer Vision and RFID-Based System for Multiple Mouse Tracking and Behavioral Assessment

    By Tony Fong, Timothy Murphy| eneuro.org@ AbstractPyMouseTracks (PMT) is a scalable and customizable computer vision and radio frequency identification (RFID)-based system for multiple rodent tracking and behavior assessment that can be set up within minutes in any user-defined arena at minimal cost. PMT is composed of the online Raspberry Pi (RPi)-based video and RFID acquisition with subsequent offline analysis tools. The system is capable of tracking up to six mice in experiments ranging from minutes to days.

    By Tony Fong, Timothy Murphy · eneuro.org

    May. 01, 2023

  • Oxford Immunotec Draws on PerkinElmer Capabilities to Automate Latent TB Test

    By Tony Fong| 360Dx Verified NEW YORK – Since its acquisition by PerkinElmer earlier this year, Oxford Immunotec has been leveraging the capabilities of its parent company to accelerate the development and reduce the costs of its technologies, according to company executives. Since the acquisition was first announced in January, Waltham, Massachusetts-based PerkinElmer has been largely mum on Oxford Immunotec.

    By Tony Fong · 360Dx

    Nov. 03, 2021

  • PerkinElmer CEO Talks COVID-19, Long-Term Outlook at JP Morgan

    By Tony Fong| GenomeWeb Verified NEW YORK – PerkinElmer kicked off the 39th Annual JP Morgan Healthcare Conference by providing an overview of 2020 with some projections for the year ahead and beyond. Prior to its presentation, the firm announced that Q4 2020 revenues are expected to be about 66 percent above Q4 2019 levels on a reported basis and about 63 percent above the year-ago figure organically.

    By Tony Fong · GenomeWeb

    Jan. 11, 2021

As seen in

Company Info

GenomeWeb

GenomeWeb is an independent online news organization based in New York, established in 1997. It serves the global community of scientists, technology professionals, and executives involved in molecular biology research and molecular diagnostics. As a business unit of Crain Communications, GenomeWeb focuses on delivering comprehensive news coverage and in-depth analysis in the fields of genomics and molecular diagnostics. The organization operates the largest online newsroom dedicated to advanced molecular research tools, providing exclusive news and insights. Key offerings include detailed news and analysis of scientific advancements, premium content for subscribers, access to data centers and research reports, and newsletters to keep professionals updated on the latest developments. GenomeWeb's audience includes major scientific organizations, biopharmaceutical companies, research universities, and clinical labs, making it a vital resource in the genomics sector.

New York, New York, United States

+1 212-269-4747

Founded: 1997